Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.73 |
| ▸ | MAOB | P27338 | 4/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.58 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.58 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 5/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | KDM4A | O75164 | 2/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15966133 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL15966143 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL9274175 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL7190739 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL9275367 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL278595 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL9131293 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL10352566 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL2326491 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 | |
| SCHEMBL11040881 | 1.00 | SIGMAR1 (0.73) | SIGMAR1MAOBMAOACARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041796-A1 | ANTI-INFLAMMATORY COMPOSITION COMPRISING N-BENZYL-N-METHYLDECAN-1-AMINE OR A DERIVATIVE THEREOF AS AN ACTIVE INGREDIENT | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2024-02-08 | — | — | US | disclosed |
| US-20240041796-A1 | ANTI-INFLAMMATORY COMPOSITION COMPRISING N-BENZYL-N-METHYLDECAN-1-AMINE OR A DERIVATIVE THEREOF AS AN ACTIVE INGREDIENT | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2024-02-08 | — | — | US | disclosed |
| US-20240041796-A1 | ANTI-INFLAMMATORY COMPOSITION COMPRISING N-BENZYL-N-METHYLDECAN-1-AMINE OR A DERIVATIVE THEREOF AS AN ACTIVE INGREDIENT | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2024-02-08 | — | — | US | disclosed |
| CN-117482074-A | Anti-inflammatory composition comprising N-benzyl-N-methyl-dec-1-amine or derivative thereof as active ingredient | 釜山大学校产学协力团 | 2024-02-02 | — | — | CN | disclosed |
| CN-117482074-A | Anti-inflammatory composition comprising N-benzyl-N-methyl-dec-1-amine or derivative thereof as active ingredient | 釜山大学校产学协力团 | 2024-02-02 | — | — | CN | disclosed |
| CN-117482074-A | Anti-inflammatory composition comprising N-benzyl-N-methyl-dec-1-amine or derivative thereof as active ingredient | 釜山大学校产学协力团 | 2024-02-02 | — | — | CN | disclosed |
| US-9315670-B2 | Composition for forming resist underlayer film and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20160041465-A1 | PATTERN FORMING METHOD, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2016-02-11 | — | — | US | disclosed |
| US-20140235796-A1 | COMPOSITION FOR FORMING RESIST UNDERLAYER FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| CN-1151719-C | Disinfectant | 日华化学株式会社 | 2004-06-02 | — | — | CN | disclosed |
| CN-1177441-A | Disinfectant | NIPPON PEROXIDE CO LTD (JP) | 1998-04-01 | — | — | CN | disclosed |
| US-5128390-A | Tertiary amine or zwitterion | HALLIBURTON COMPANY (US) | 1992-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041796-A1 | ANTI-INFLAMMATORY COMPOSITION COMPRISING N-BENZYL-N-METHYLDECAN-1-AMINE OR A DERIVATIVE THEREOF AS AN ACTIVE INGREDIENT | IL1B, NOS1, FPR1 | SIGMAR1 319/4885MAOB 1469/4885MAOA 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.